vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and SILICOM LTD. (SILC). Click either name above to swap in a different company.

SILICOM LTD. is the larger business by last-quarter revenue ($61.9M vs $38.9M, roughly 1.6× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs -18.5%, a 43.2% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 6.6%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $-3.3M).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Silicom Ltd. is a publicly traded company, headquartered in Israel, that specializes in the design, manufacture and marketing of connectivity solutions for a range of servers and server-based systems. Its shares are listed on the NASDAQ Global Market and on the Tel Aviv Stock Exchange. Silicom is a member of the RAD Group family of companies.

CDXS vs SILC — Head-to-Head

Bigger by revenue
SILC
SILC
1.6× larger
SILC
$61.9M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+74.8% gap
CDXS
81.3%
6.6%
SILC
Higher net margin
CDXS
CDXS
43.2% more per $
CDXS
24.7%
-18.5%
SILC
More free cash flow
CDXS
CDXS
$22.9M more FCF
CDXS
$19.6M
$-3.3M
SILC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
SILC
SILC
Revenue
$38.9M
$61.9M
Net Profit
$9.6M
$-11.5M
Gross Margin
94.8%
30.6%
Operating Margin
27.1%
-19.8%
Net Margin
24.7%
-18.5%
Revenue YoY
81.3%
6.6%
Net Profit YoY
192.5%
16.3%
EPS (diluted)
$0.13
$-2.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
SILC
SILC
Q4 25
$38.9M
$61.9M
Q3 25
$8.6M
Q2 25
$15.3M
Q1 25
$7.5M
Q4 24
$21.5M
$58.1M
Q3 24
$12.8M
Q2 24
$8.0M
Q1 24
$17.1M
Net Profit
CDXS
CDXS
SILC
SILC
Q4 25
$9.6M
$-11.5M
Q3 25
$-19.6M
Q2 25
$-13.3M
Q1 25
$-20.7M
Q4 24
$-10.4M
$-13.7M
Q3 24
$-20.6M
Q2 24
$-22.8M
Q1 24
$-11.5M
Gross Margin
CDXS
CDXS
SILC
SILC
Q4 25
94.8%
30.6%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
28.6%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
SILC
SILC
Q4 25
27.1%
-19.8%
Q3 25
-220.3%
Q2 25
-83.9%
Q1 25
-271.6%
Q4 24
-34.2%
-22.8%
Q3 24
-129.0%
Q2 24
-284.9%
Q1 24
-69.6%
Net Margin
CDXS
CDXS
SILC
SILC
Q4 25
24.7%
-18.5%
Q3 25
-228.1%
Q2 25
-86.6%
Q1 25
-274.3%
Q4 24
-48.4%
-23.6%
Q3 24
-160.8%
Q2 24
-285.2%
Q1 24
-67.4%
EPS (diluted)
CDXS
CDXS
SILC
SILC
Q4 25
$0.13
$-2.01
Q3 25
$-0.22
Q2 25
$-0.16
Q1 25
$-0.25
Q4 24
$-0.12
$-2.28
Q3 24
$-0.29
Q2 24
$-0.32
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
SILC
SILC
Cash + ST InvestmentsLiquidity on hand
$78.2M
$42.1M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$117.5M
Total Assets
$147.8M
$152.2M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
SILC
SILC
Q4 25
$78.2M
$42.1M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
$72.1M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
Total Debt
CDXS
CDXS
SILC
SILC
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
SILC
SILC
Q4 25
$50.5M
$117.5M
Q3 25
$38.5M
Q2 25
$55.6M
Q1 25
$49.6M
Q4 24
$66.9M
$127.8M
Q3 24
$73.4M
Q2 24
$61.4M
Q1 24
$79.3M
Total Assets
CDXS
CDXS
SILC
SILC
Q4 25
$147.8M
$152.2M
Q3 25
$124.0M
Q2 25
$138.2M
Q1 25
$128.9M
Q4 24
$149.0M
$150.4M
Q3 24
$148.2M
Q2 24
$132.0M
Q1 24
$149.6M
Debt / Equity
CDXS
CDXS
SILC
SILC
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
SILC
SILC
Operating Cash FlowLast quarter
$20.1M
$-2.2M
Free Cash FlowOCF − Capex
$19.6M
$-3.3M
FCF MarginFCF / Revenue
50.3%
-5.4%
Capex IntensityCapex / Revenue
1.3%
1.9%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
SILC
SILC
Q4 25
$20.1M
$-2.2M
Q3 25
$-7.7M
Q2 25
$-18.0M
Q1 25
$-13.8M
Q4 24
$-16.5M
$18.3M
Q3 24
$-13.0M
Q2 24
$-12.2M
Q1 24
$-7.8M
Free Cash Flow
CDXS
CDXS
SILC
SILC
Q4 25
$19.6M
$-3.3M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
$17.4M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
CDXS
CDXS
SILC
SILC
Q4 25
50.3%
-5.4%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
29.9%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
CDXS
CDXS
SILC
SILC
Q4 25
1.3%
1.9%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
1.6%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
CDXS
CDXS
SILC
SILC
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons